Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness

  title={Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness},
  author={Donna J. Lang and Alasdair M Barr and Ric M Procyshyn},
  booktitle={Current Cardiovascular Risk Reports},
Severe psychotic disorders, which on their own may be a risk factor for metabolic disorder and cardiovascular illness, are clinically compounded by the significant adverse side effects of antipsychotic medications. The majority of patients with severe psychotic disorders (i.e., schizophrenia, bipolar disorder, mania, and depression) must take antipsychotic medications to treat their psychoses and, subsequently, will require efficacious interventions to manage the metabolic consequences of… CONTINUE READING
Highlighted Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications referenced by this paper.

Physiological evidence of increased cardiovascular disease risk in schizophrenia-spectrum disorders: a pilot study using aortic pulse wave velocity and arterial compliance

  • AA Phillips, DE Warburton, SW Flynn, D Fredikson, DJ. Lang
  • 2013

Cardiovascular disease in severe mental illness

  • IM Bensenor, AR Brunoni, LA Pilan, AC Goulart, GF Busatto, PA Lotufo
  • Gen Hosp Psychiat
  • 2012
1 Excerpt